Sfoglia per Rivista
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML
2016-01-01 S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio
Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
2002-01-01 Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio
ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE
2013-01-01 Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA
2013-01-01 Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY
2015-01-01 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive?
2016-01-01 Ferrero, Simone
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation
2010-01-01 Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A
SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION
2006-01-01 L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
2014-01-01 T. P. Hughes;A. Hochhaus;H. M. Kantarjian;F. Cervantes;F. Guilhot;D. Niederwieser;P. D. le Coutre;G. Rosti;G. Ossenkoppele;C. Lobo;H. Shibayama;X. Fan;H. D. Menssen;C. Kemp;R. A. Larson;G. Saglio
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
2013-01-01 Palumbo A1; Waage A; Hulin C; Beksac M; Zweegman S; Gay F; Gimsing P; Leleu X; Wijermans P; Sucak G; Pezzatti S; Juliusson G; Pégourié B; Schaafsma M; Galli M; Turesson I; Kolb B; van der Holt B; Baldi I; Rolke J; Ciccone G; Wetterwald M; Lokhorst H; Boccadoro M; Rodon P; Sonneveld P.
Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin.
1990-01-01 ALFARANO A.; GOTTARDI E.; SERRA A.; PIGA A.; MANDRINO M.; MAZZA U.; CAMASCHELLA C.
Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
2004-01-01 M. De Gobbi;S. D'Antico;F. Castagno;D. Testa;R. Merlini;A. Bondi;C. Camaschella
se of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation.
1990-01-01 Tarella C; Gavarotti P; Caracciolo D; Locatelli F; Falda M; Paolino F; Lovisone E; Sormano E; Tassi V; Urgesi A; et al.
SECOND GENERATION TYROSINE KINASE INHIBITORS CAN INDUCE COMPLETE MOLECULAR RESPONSE IN PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANT
2010-01-01 Ulisciani S; Fava C; Falda M; Locatelli F;Busca A; D'Ardia S; Gottardi E; Daraio F; Giugliano E; Giaretto L; Saglio G; Rege Cambrin G
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi
2017-01-01 Zaja, Francesco; Ferrero, Simone; Stelitano, Caterina; Ferrari, Angela; Salvi, Flavia; Arcari, Annalisa; Musuraca, Gerardo; Botto, Barbara; Spina, Michele; Cellini, Claudia; Patti, Caterina; Liberati, Anna M.; Minotto, Claudia; Pileri, Stefano A.; Ceccarelli, Manuela; Volpetti, Stefano; Ferranti, Antonella; Drandi, Daniela; Montechiarello, Elisa; Ladetto, Marco; Carmichael, James; Fanin, Renato
Secondary myelodisplastic syndromes in childhood: a diagnostic suirveillance protocol
2005-01-01 Farinasso L.; Garbarini L.; Saracco P.; Crescenzio N.; Basso M.E.; Aschero S.; Doria A.; Iavarone A; Linari A.; Gottardi E.; Ramenghi U.; Cordero di Montezemolo L.; Timeus F.
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE
2018-01-01 Todaro, M; Griggio, V; Vitale, C; Salvetti, C; Riganti, C; Boccadoro, M; Coscia, M
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL)
2012-01-01 Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML | 2016 | S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio | |
| Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) | 2002 | Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio | |
| ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE | 2013 | Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F | |
| ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA | 2013 | Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont | |
| ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY | 2015 | G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti | |
| The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive? | 2016 | Ferrero, Simone | |
| ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
| Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation | 2010 | Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A | |
| SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION | 2006 | L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro | |
| Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily | 2014 | T. P. Hughes;A. Hochhaus;H. M. Kantarjian;F. Cervantes;F. Guilhot;D. Niederwieser;P. D. le Coutre;G. Rosti;G. Ossenkoppele;C. Lobo;H. Shibayama;X. Fan;H. D. Menssen;C. Kemp;R. A. Larson;G. Saglio | |
| Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials. | 2013 | Palumbo A1; Waage A; Hulin C; Beksac M; Zweegman S; Gay F; Gimsing P; Leleu X; Wijermans P; Sucak G; Pezzatti S; Juliusson G; Pégourié B; Schaafsma M; Galli M; Turesson I; Kolb B; van der Holt B; Baldi I; Rolke J; Ciccone G; Wetterwald M; Lokhorst H; Boccadoro M; Rodon P; Sonneveld P. | |
| Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin. | 1990 | ALFARANO A.; GOTTARDI E.; SERRA A.; PIGA A.; MANDRINO M.; MAZZA U.; CAMASCHELLA C. | |
| Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. | 2004 | M. De Gobbi;S. D'Antico;F. Castagno;D. Testa;R. Merlini;A. Bondi;C. Camaschella | |
| se of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation. | 1990 | Tarella C; Gavarotti P; Caracciolo D; Locatelli F; Falda M; Paolino F; Lovisone E; Sormano E; Tassi V; Urgesi A; et al. | |
| SECOND GENERATION TYROSINE KINASE INHIBITORS CAN INDUCE COMPLETE MOLECULAR RESPONSE IN PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANT | 2010 | Ulisciani S; Fava C; Falda M; Locatelli F;Busca A; D'Ardia S; Gottardi E; Daraio F; Giugliano E; Giaretto L; Saglio G; Rege Cambrin G | |
| Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi | 2017 | Zaja, Francesco; Ferrero, Simone; Stelitano, Caterina; Ferrari, Angela; Salvi, Flavia; Arcari, Annalisa; Musuraca, Gerardo; Botto, Barbara; Spina, Michele; Cellini, Claudia; Patti, Caterina; Liberati, Anna M.; Minotto, Claudia; Pileri, Stefano A.; Ceccarelli, Manuela; Volpetti, Stefano; Ferranti, Antonella; Drandi, Daniela; Montechiarello, Elisa; Ladetto, Marco; Carmichael, James; Fanin, Renato | |
| Secondary myelodisplastic syndromes in childhood: a diagnostic suirveillance protocol | 2005 | Farinasso L.; Garbarini L.; Saracco P.; Crescenzio N.; Basso M.E.; Aschero S.; Doria A.; Iavarone A; Linari A.; Gottardi E.; Ramenghi U.; Cordero di Montezemolo L.; Timeus F. | |
| SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE | 2018 | Todaro, M; Griggio, V; Vitale, C; Salvetti, C; Riganti, C; Boccadoro, M; Coscia, M | |
| Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) | 2012 | Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile